Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 2
2012 1
2013 2
2014 3
2015 6
2016 5
2017 6
2018 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Pharmacogenomics and the treatment of acute myeloid leukemia.
Megías-Vericat JE, Montesinos P, Herrero MJ, Bosó V, Martínez-Cuadrón D, Poveda JL, Sanz MÁ, Aliño SF. Megías-Vericat JE, et al. Among authors: boso v. Pharmacogenomics. 2016 Jul;17(11):1245-1272. doi: 10.2217/pgs-2016-0055. Epub 2016 Jul 6. Pharmacogenomics. 2016. PMID: 27381050 Review.
A systematic review and meta-analysis of the impact of WT1 polymorphism rs16754 in the effectiveness of standard chemotherapy in patients with acute myeloid leukemia.
Megías-Vericat JE, Herrero MJ, Rojas L, Montesinos P, Bosó V, Moscardó F, Martínez-Cuadrón D, Poveda JL, Sanz MÁ, Aliño SF. Megías-Vericat JE, et al. Among authors: boso v. Pharmacogenomics J. 2016 Feb;16(1):30-40. doi: 10.1038/tpj.2015.80. Epub 2015 Dec 8. Pharmacogenomics J. 2016. PMID: 26644203 Review.
Positive impact of ABCB1 polymorphisms in overall survival and complete remission in acute myeloid leukemia: a systematic review and meta-analysis.
Megías-Vericat JE, Rojas L, Herrero MJ, Bosó V, Montesinos P, Moscardó F, Poveda JL, Sanz MA, Aliño SF. Megías-Vericat JE, et al. Among authors: boso v. Pharmacogenomics J. 2016 Feb;16(1):1-2. doi: 10.1038/tpj.2015.79. Epub 2015 Oct 27. Pharmacogenomics J. 2016. PMID: 26503809 Review. No abstract available.
SNPs and taxane toxicity in breast cancer patients.
Bosó V, Herrero MJ, Santaballa A, Palomar L, Megias JE, de la Cueva H, Rojas L, Marqués MR, Poveda JL, Montalar J, Aliño SF. Bosó V, et al. Pharmacogenomics. 2014;15(15):1845-58. doi: 10.2217/pgs.14.127. Pharmacogenomics. 2014. PMID: 25495407
Impact of NADPH oxidase functional polymorphisms in acute myeloid leukemia induction chemotherapy.
Megías-Vericat JE, Montesinos P, Herrero MJ, Moscardó F, Bosó V, Rojas L, Martínez-Cuadrón D, Rodríguez-Veiga R, Sendra L, Cervera J, Poveda JL, Sanz MÁ, Aliño SF. Megías-Vericat JE, et al. Among authors: boso v. Pharmacogenomics J. 2018 Apr;18(2):301-307. doi: 10.1038/tpj.2017.19. Epub 2017 May 9. Pharmacogenomics J. 2018. PMID: 28485375 Clinical Trial.
Influence of cytarabine metabolic pathway polymorphisms in acute myeloid leukemia induction treatment.
Megías-Vericat JE, Montesinos P, Herrero MJ, Moscardó F, Bosó V, Martínez-Cuadrón D, Rojas L, Rodríguez-Veiga R, Boluda B, Sendra L, Cervera J, Poveda JL, Sanz MÁ, Aliño SF. Megías-Vericat JE, et al. Among authors: boso v. Leuk Lymphoma. 2017 Dec;58(12):2880-2894. doi: 10.1080/10428194.2017.1323267. Epub 2017 Jun 2. Leuk Lymphoma. 2017. PMID: 28573946
19 results